Immunotherapy: The Future of Prostate Cancer is Here, with Charles Drake

On September 30, 2014, Charles G. Drake, M.D., Ph.D., an associate professor of oncology at Johns Hopkins University, discussed current immunotherapy treatment options for patients with prostate cancer, and how close we are to making these treatments available to more patients.

This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, was generously supported by Dendreon.